Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05009082
Title Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
Recruitment Not yet recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors AGO Study Group

ovary epithelial cancer

fallopian tube cancer

peritoneum cancer


Carboplatin + Niraparib + Paclitaxel

Bevacizumab + Niraparib

Bevacizumab + Carboplatin + Paclitaxel

Age Groups: adult | senior
Covered Countries

No variant requirements are available.